New Zealand's Medsafe Grants Provisional Approval for Novava

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

Mexico , Australia , New Zealand , India , Zealand Medsafe , Laura Keenan Lindsey , Zealand Datasheet , Erika Schultz , Stanleyc Erck , Alexandra Roy , Ali Chartan , Anne Marie Sparrow , Biocelect Pty , Linkedin , World Health Organization , European Commission , Drug Administration , Prnewswire Novavax Inc , Nasdaq , Exchange Commission , Administration Of Nuvaxovid , European Union , Serum Institute , Serum Institute Of India , Novavax Inc , Therapeutic Goods Administration , Chief Executive Officer , New England Journal , New Zealand Government , New Zealand Datasheet , Consumer Medicine Information , Important Safety Information , New Zealand Consumer Medicine , New Zealand Medsafe , Conditional Marketing Authorization , Emergency Use Listing , World Health , Financial Condition , Novavax Annual Report , Quarterly Reports , Keenan Lindsey , Novavax , Nc ,